COMMENTARY

Seven Pharmacotherapies Do Promote Smoking Abstinence at 6 and 12 Months


This feature requires the newest version of Flash. You can download it here.
This feature requires the newest version of Flash. You can download it here.

This is the Medscape Medical Minute. I'm Dr. George Lundberg.

Tobacco addiction remains the top killer of humans in the developed world. But most smokers want to quit. How can we help them? Ten investigators from Montreal performed a meta-analysis of 69 published double-blind, randomized, placebo-controlled trials of 7 approved pharmacotherapies for smoking cessation. Published in the CMAJ in 2008,[1] these studies, found in 4 large databases, included biochemically validated measures of abstinence at 6 and 12 months. Odds ratios of efficacy compared with placebo ranged from the top of 2.41 for varenicline to the low of 1.71 for nicotine gum. Take your pick. All 7 help to promote abstinence from smoking tobacco.

This article is selected from Medscape Best Evidence.[2] I'm Dr George Lundberg.


Reader Comments on: Seven Pharmacotherapies Do Promote Smoking Abstinence at 6 and 12 Months
See reader comments on this article and provide your own.

Readers are encouraged to respond to Peter Yellowlees, MD, Deputy Editor of The Medscape Journal of Medicine, for the editor's eyes only or for possible publication as an actual Letter in the Medscape Journal via email: peter.yellowlees@ucdmc.ucdavis.edu

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....